MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Myriad Genetics Depreciation & Amortization 2011-2026 | MYGN
Annual Depreciation & Amortization Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.7 M | 61.2 M | 61.9 M | 52.7 M | 62.8 M | 35.8 M | 73 M | 54.4 M | 48.3 M | 26.8 M | 25 M | 13.8 M | 8.89 M | 9.07 M | 7.22 M | 7.08 M | 9.45 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73 M | 7.08 M | 35.9 M |
Quarterly Depreciation & Amortization Myriad Genetics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 M | 4.8 M | 4.9 M | 14.4 M | - | 4.8 M | 4.6 M | 15.7 M | - | 3.4 M | 2.7 M | 19.4 M | - | 2.9 M | 2.8 M | 13 M | - | 49.5 M | 16.9 M | 18.4 M | - | 17.7 M | 17.7 M | 17.7 M | 18.2 M | 18.2 M | 36.4 M | 18.2 M | 18 M | 18.3 M | 18 M | 18.3 M | 13.1 M | 13.2 M | 13.1 M | 13.2 M | 12.9 M | 9.2 M | 13 M | 9.2 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6 M | 6 M | 6.04 M | 5.95 M | 2.44 M | 2.37 M | 2.44 M | 2.37 M | 2.21 M | 2.21 M | 4.46 M | 275 K | 275 K | 2.15 M | 4.44 M | 2.15 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.5 M | 275 K | 10.6 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
167 K | $ 88.28 | -4.53 % | $ 4.13 B | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 5.63 | -2.26 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
40.8 M | $ 21.01 | -2.73 % | $ 609 M | USA |
 |
Fulgent Genetics
FLGT
|
24.1 M | $ 19.15 | -1.79 % | $ 589 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.4 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 125.61 | -5.6 % | $ 15.7 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.67 | -6.7 % | $ 7.39 M | USA |
 |
Illumina
ILMN
|
270 M | $ 162.32 | -3.42 % | $ 25.2 B | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 22.25 | -3.76 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
383 M | $ 149.45 | -2.19 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 100.98 | -1.79 % | $ 6.82 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 10.9 | -3.63 % | $ 1.4 B | USA |
 |
Natera
NTRA
|
41.8 M | $ 215.31 | -3.06 % | $ 29.4 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 181.34 | -2.4 % | $ 8.99 B | USA |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.45 | -11.04 % | $ 435 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 454.25 | -0.97 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 154.33 | -2.22 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 19.14 | -3.09 % | $ 428 M | USA |
 |
Personalis
PSNL
|
10 M | $ 10.75 | -11.16 % | $ 959 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 26.11 | 0.46 % | $ 24.8 B |  Niderland |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 6.67 | -4.85 % | $ 278 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.12 | -1.17 % | $ 4.87 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 265.15 | 1.6 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 69.22 | -6.37 % | $ 4.14 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 472.8 | -1.91 % | $ 178 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
88.1 M | $ 365.36 | -2.95 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 8.9 | -2.41 % | $ 1.93 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 200.29 | 2.13 % | $ 22.2 B | USA |